Patent Issued for Diagnosing fetal chromosomal aneuploidy using genomic sequencing (USPTO 12180549).

A patent has been issued for a method of diagnosing fetal chromosomal aneuploidy using genomic sequencing by the Chinese University of Hong Kong. The method aims to overcome limitations of current prenatal diagnostic methods by analyzing nucleic acid sequences from a biological sample obtained from a pregnant female. By comparing the amount of sequences from different chromosomes, the presence or absence of fetal aneuploidy can be determined with increased sensitivity and accuracy. This method offers a non-invasive approach to prenatal diagnosis, potentially minimizing false negatives and false positives. [Extracted from the article]